Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine.

Dlugos AM, Hamidovic A, Hodgkinson CA, Goldman D, Palmer AA, de Wit H.

Neuropsychopharmacology. 2010 Feb;35(3):613-22. doi: 10.1038/npp.2009.166. Epub 2009 Nov 4.

2.

Norepinephrine transporter gene variation modulates acute response to D-amphetamine.

Dlugos A, Freitag C, Hohoff C, McDonald J, Cook EH, Deckert J, de Wit H.

Biol Psychiatry. 2007 Jun 1;61(11):1296-305. Epub 2007 Jan 17.

PMID:
17239355
3.

Further evidence of association between amphetamine response and SLC6A2 gene variants.

Dlugos AM, Hamidovic A, Palmer AA, de Wit H.

Psychopharmacology (Berl). 2009 Oct;206(3):501-11. doi: 10.1007/s00213-009-1628-y.

4.

Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.

Kirkpatrick MG, Goldenson NI, Kapadia N, Kahler CW, de Wit H, Swift RM, McGeary JE, Sussman S, Leventhal AM.

Psychopharmacology (Berl). 2016 Jan;233(1):89-97. doi: 10.1007/s00213-015-4091-y. Epub 2015 Oct 2.

5.

Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer.

Cajanus K, Holmström EJ, Wessman M, Anttila V, Kaunisto MA, Kalso E.

Pain. 2016 Feb;157(2):361-9. doi: 10.1097/j.pain.0000000000000398.

PMID:
26808012
6.

Rapid screening for potentially relevant polymorphisms in the human fatty acid amide hydrolase gene using Pyrosequencing.

Doehring A, Geisslinger G, Lötsch J.

Prostaglandins Other Lipid Mediat. 2007 Nov;84(3-4):128-37. Epub 2007 Jun 22.

PMID:
17991615
7.

OPRM1 gene variants modulate amphetamine-induced euphoria in humans.

Dlugos AM, Hamidovic A, Hodgkinson C, Shen PH, Goldman D, Palmer AA, de Wit H.

Genes Brain Behav. 2011 Mar;10(2):199-209. doi: 10.1111/j.1601-183X.2010.00655.x. Epub 2010 Nov 2.

8.

Dopamine transporter gene associated with diminished subjective response to amphetamine.

Lott DC, Kim SJ, Cook EH Jr, de Wit H.

Neuropsychopharmacology. 2005 Mar;30(3):602-9.

9.

The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction.

Flanagan JM, Gerber AL, Cadet JL, Beutler E, Sipe JC.

Hum Genet. 2006 Nov;120(4):581-8. Epub 2006 Sep 14.

PMID:
16972078
10.

Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity.

Müller TD, Brönner G, Wandolski M, Carrie J, Nguyen TT, Greene BH, Scherag A, Grallert H, Vogel CI, Scherag S, Rief W, Wichmann HE, Illig T, Schäfer H, Hebebrand J, Hinney A.

BMC Med Genet. 2010 Jan 1;11:2. doi: 10.1186/1471-2350-11-2.

11.

Serotonin transporter genotype and acute subjective response to amphetamine.

Lott DC, Kim SJ, Cook EH, de Wit H.

Am J Addict. 2006 Sep-Oct;15(5):327-35.

PMID:
16966188
12.

Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome.

Jiang Y, Nie Y, Li Y, Zhang L.

J Gastroenterol Hepatol. 2014 Jun;29(6):1186-91. doi: 10.1111/jgh.12513.

PMID:
24444427
13.

A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia.

Morita Y, Ujike H, Tanaka Y, Uchida N, Nomura A, Ohtani K, Kishimoto M, Morio A, Imamura T, Sakai A, Inada T, Harano M, Komiyama T, Yamada M, Sekine Y, Iwata N, Iyo M, Sora I, Ozaki N, Kuroda S.

Neurosci Lett. 2005 Mar 16;376(3):182-7. Epub 2004 Dec 9.

PMID:
15721218
14.

Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.

Monteleone P, Bifulco M, Di Filippo C, Gazzerro P, Canestrelli B, Monteleone F, Proto MC, Di Genio M, Grimaldi C, Maj M.

Genes Brain Behav. 2009 Oct;8(7):728-32. doi: 10.1111/j.1601-183X.2009.00518.x. Epub 2009 Jun 26.

15.

Evaluating the association of FAAH common gene variation with childhood, adult severe obesity and type 2 diabetes in the French population.

Durand E, Lecoeur C, Delplanque J, Benzinou M, Degraeve F, Boutin P, Marre M, Balkau B, Charpentier G, Froguel P, Meyre D.

Obes Facts. 2008;1(6):305-9. doi: 10.1159/000178157. Epub 2008 Dec 12.

16.

The role of fatty acid hydrolase gene variants in inflammatory bowel disease.

Storr M, Emmerdinger D, Diegelmann J, Yüce B, Pfennig S, Ochsenkühn T, Göke B, Lohse P, Brand S.

Aliment Pharmacol Ther. 2009 Mar 1;29(5):542-51. doi: 10.1111/j.1365-2036.2008.03910.x. Epub 2008 Dec 2.

17.

Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans.

Melroy-Greif WE, Wilhelmsen KC, Ehlers CL.

Drug Alcohol Depend. 2016 Sep 1;166:249-53. doi: 10.1016/j.drugalcdep.2016.06.021. Epub 2016 Jun 25.

18.
19.

Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.

Monteleone P, Bifulco M, Maina G, Tortorella A, Gazzerro P, Proto MC, Di Filippo C, Monteleone F, Canestrelli B, Buonerba G, Bogetto F, Maj M.

Pharmacol Res. 2010 May;61(5):400-4. doi: 10.1016/j.phrs.2010.01.002. Epub 2010 Jan 18.

PMID:
20080186
20.

The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: studies of drug use and dependence in Caucasians.

Tyndale RF, Payne JI, Gerber AL, Sipe JC.

Am J Med Genet B Neuropsychiatr Genet. 2007 Jul 5;144B(5):660-6.

PMID:
17290447

Supplemental Content

Support Center